Research ArticleCancer

Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin

See allHide authors and affiliations

Science Translational Medicine  20 Jul 2016:
Vol. 8, Issue 348, pp. 348ra97
DOI: 10.1126/scitranslmed.aaf3124

Log in to view Figures & Data

Log in through your institution

Log in through your institution